These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 3911212

  • 1. Fetal liver infusion: an adjuvant in the therapy of acute myeloid leukemia (AML).
    Kochupillai V, Sharma S, Francis S, Mehra NK, Nanu A, Verma IC, Takkar D, Kumar S, Gokhale U.
    Prog Clin Biol Res; 1985; 193():267-79. PubMed ID: 3911212
    [No Abstract] [Full Text] [Related]

  • 2. The role of peripheral blood stem cells as rescue after myeloablative therapy.
    Reiffers J, Marit G, Boiron JM, Rice A, Bernard P, Vezon G.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():212-4. PubMed ID: 2565746
    [No Abstract] [Full Text] [Related]

  • 3. [Acute myeloid leukemia trials by Japan Adult Leukemia Study Group (JALSG)].
    Miyazaki Y.
    Rinsho Ketsueki; 2009 Aug; 50(8):611-6. PubMed ID: 19915375
    [No Abstract] [Full Text] [Related]

  • 4. Allogeneic fetal liver transplantation in acute leukemia.
    Meng PL, Fei RG, Gu DW, Yie WZ, Liu BT, Yan F, Yu YY, Mai ZG, Chen BZ, Zhu LX.
    Prog Clin Biol Res; 1985 Aug; 193():281-91. PubMed ID: 3911213
    [Abstract] [Full Text] [Related]

  • 5. Two cases of post-liver transplant acute myeloid leukemia in Korean adults: review of bibliographies and comparison with post-renal transplant acute myeloid leukemia.
    Cho YU, Chi HS, Park CJ, Seo EJ, Lee JH, Lee JH, Lee SG.
    Ann Hematol; 2008 Jun; 87(6):513-4. PubMed ID: 18299830
    [No Abstract] [Full Text] [Related]

  • 6. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
    Camera A, Rinaldi CR, Palmieri S, Cantore N, Mele G, Mettivier V, Miraglia E, Mastrullo L, Grimaldi F, Luciano L, Guerriero A, Rotoli B, Ferrara F.
    Ann Hematol; 2009 Feb; 88(2):151-8. PubMed ID: 18709502
    [Abstract] [Full Text] [Related]

  • 7. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T, Hiddemann W, Berdel WE, Wörmann B, Schoch C, Fonatsch C, Löffler H, Haferlach T, Ludwig WD, Maschmeyer G, Staib P, Aul C, Gruneisen A, Lengfelder E, Frickhofen N, Kern W, Serve HL, Mesters RM, Sauerland MC, Heinecke A, German AML Cooperative Group.
    J Clin Oncol; 2003 Dec 15; 21(24):4496-504. PubMed ID: 14673036
    [Abstract] [Full Text] [Related]

  • 8. Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.
    Hołowiecki J, Grosicki S, Kyrcz-Krzemien S, Skotnicki AB, Piatkowska-Jakubas B, Warzocha K, Seferynska I, Zdziarska B.
    Ann Hematol; 2008 May 15; 87(5):361-7. PubMed ID: 18074133
    [Abstract] [Full Text] [Related]

  • 9. Cure of acute myelocytic leukemia in adults: a reality.
    Geller RB, Saral R, Karp JE, Santos GW, Burke PJ.
    Leukemia; 1990 May 15; 4(5):313-5. PubMed ID: 2201825
    [Abstract] [Full Text] [Related]

  • 10. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
    Hübner G, Link H, Schönrock-Nabulsi P, Wandt H, Gramatzki M, Löffler B, Fackler-Schwalbe I, Queisser W, Brack N, Geer T, Raab M, Ohl S, Schneider B, Schneider C, Freund M, Poliwoda H, Ehninger G.
    Med Klin (Munich); 1996 Apr 12; 91 Suppl 3():26-32. PubMed ID: 8692115
    [Abstract] [Full Text] [Related]

  • 11. Long term results in acute non-lymphocytic leukaemia.
    Saikia TK, Rajni A, Gopal R, Nair CN, Nadkarni KS, Kurkure PA, Pai VR, Pai SK, Advani SH.
    J Assoc Physicians India; 1988 Aug 12; 36(8):505-7. PubMed ID: 3073153
    [No Abstract] [Full Text] [Related]

  • 12. Acute myeloid leukemia in adults: experience at AIIMS.
    Raina V, Kochupillai V.
    J Assoc Physicians India; 1983 Aug 12; 31(8):511-4. PubMed ID: 6581155
    [No Abstract] [Full Text] [Related]

  • 13. Results of the Italian AIEOP/LAM 8204 study for the treatment of childhood AML: an update.
    Amadori S, Mandelli F, Ceci A, Comelli A, Madon E, Masera G, Nespoli L, Paolucci G, Zanesco L, Defazio D.
    Bone Marrow Transplant; 1989 Jan 12; 4 Suppl 1():114-5. PubMed ID: 2653484
    [No Abstract] [Full Text] [Related]

  • 14. Combination chemotherapy with DATV regimen in treatment of adult acute nonlymphocytic leukemia.
    Lou FD, Zhou Q, Liu HC, Meng FY, Wang YZ.
    Chin Med J (Engl); 1993 Nov 12; 106(11):876-8. PubMed ID: 8143502
    [No Abstract] [Full Text] [Related]

  • 15. Design and conduct of a double-blind, placebo-controlled trial of daunorubicin and cytarabine with or without granulocyte colony-stimulating factor in elderly patients with acute myeloid leukemia: a Southwest Oncology Group study.
    Godwin J.
    J Natl Cancer Inst Monogr; 1995 Nov 12; (19):31-5. PubMed ID: 7577202
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Outcome of acute myeloid leukaemia in adults: a retrospective analysis.
    Saikia TK, Bakshi A, Bhagwat R, Tawde S, Nair R, Nair CN, Parikh PM.
    Natl Med J India; 2005 Nov 12; 18(1):12-5. PubMed ID: 15835484
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine.
    Sitar DS, Aoki FY, Bow EJ.
    J Clin Pharmacol; 2008 Aug 12; 48(8):995-8. PubMed ID: 18495946
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.
    Brunet S, Esteve J, Berlanga J, Ribera JM, Bueno J, Martí JM, Bargay J, Guardia R, Juliá A, Granena A, Montserrat E, Sierra J, Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias.
    Haematologica; 2004 Aug 12; 89(8):940-9. PubMed ID: 15339677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.